Advertisement

The Latest

Nearly half of consumers access healthcare portals less than once a month, and 16% say they have never used one. For payer organizations investing heavily in digital member portals, this gap between availability and engagement raises an important question: What…

Presented by:

Presented by

Spine surgery is increasingly defined by a tension few outside the field fully see: the collision of clinical complexity and economic constraint. For surgeons like Oliver Tannous, MD, an orthopedic spine surgeon at Washington, D.C.-based MedStar Washington Hospital Center, that…

In the first quarter of 2026, multiple orthopedic surgeons were honored for their work and research. Note: This is not an exhaustive list. 1. Stefano Sinicropi, MD, was named the Top Spine Surgeon of the Year 2026 by the International…

Kevin Lobo, CEO and chairman of Stryker, has been appointed to the board of directors at GE HealthCare.  Mr. Lobo has served as Stryker’s CEO since October 2012 and chair of the company’s board since July 2014, according to a…

Ali Ravanpay, MD, PhD, has been named program director of Seattle-based University of Washington’s neurological surgery residency program, according to a March 18 system LinkedIn post.  Dr. Ravanpay earned his MD and PhD through UW’s medical scientist training program and…

Cardiovascular programs are expanding fast but many health systems are struggling to keep governance, workflows and financial discipline aligned as remote monitoring volumes grow. Different billing intervals across CIED and heart failure programs, documentation requirements tied to reimbursement and fragmented…

May 20, 2026 12:00 PM - 1:00 PM America/Chicago

Presented by:

Presented by

Presenters

Dr. Kenneth Civello, MD, MPH, FACC

Louisiana Cardiology, FMOL Health

Gopi Dandamundi, MD, MBA

Founding President Heart & Vascular Institute, Prisma Health

Gordon B. Wesley, DBA, FACHE

Chief Strategy | Clinical Integration Officer, UChicagoMedicine AdventHealth

Troy Leo, MD, MHCM, FACC

Leader - Heart and Vascular Service Line, North Carolina/Georgia Division, AtriumHealth

Providence Medical Technology enrolled its first patients for a randomized controlled trial for its Corus-LX system for degenerative lumbosacral disease, according to a March 19 news release. The multicenter trial will focus on patients who qualify for two-level interbody fusion…

Advertisement